BA
NVO

Bridgewater Advisors’s Novo Nordisk NVO Stock Holding History

Bridgewater Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$536K Buy
11,380
+373
+3% +$16K 0.03% 257
2026
Q1 		$518K Sell
11,007
-749
-6% -$35.5K 0.03% 240
2025
Q4 		$697K Buy
11,756
+160
+1% +$8.18K 0.05% 195
2025
Q3 		$539K Sell
11,596
-964
-8% -$56.4K 0.04% 237
2025
Q2 		$677K Buy
12,560
+615
+5% +$41.8K 0.05% 190
2025
Q1 		$778K Sell
11,945
-447
-4% -$36.9K 0.07% 148
2024
Q4 		$1.01M Sell
12,392
-94
-0.8% -$10.2K 0.11% 87
2024
Q3 		$1.4M Sell
12,486
-20
-0.2% -$2.67K 0.15% 78
2024
Q2 		$1.6M Buy
+12,506
New +$1.66M 0.2% 68
2014
Q2 		$268K Buy
11,618
+16
+0.1% +$353 0.22% 74
2014
Q1 		$265K Buy
11,602
+402
+4% +$8.56K 0.27% 66
2013
Q4 		$207K Buy
+11,200
New +$195K 0.21% 74

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bridgewater Advisors's NVO Position: Q2 2026 in Review

Bridgewater Advisors increased its Novo Nordisk (NVO) stake by 3.4% in Q2 2026, buying an estimated $16K and bringing the position to 11,380 shares worth $536K. The position accounts for 0.03% of the portfolio, ranked #257.

Bridgewater Advisors first reported a position in NVO in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.6M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bridgewater Advisors held 11,380 shares of Novo Nordisk worth $536K as of Q2 2026.
  • Bridgewater Advisors bought 373 Novo Nordisk shares in Q2 2026, an estimated $16K.
  • Novo Nordisk made up 0.03% of Bridgewater Advisors's portfolio in Q2 2026, its #257 holding.
  • Bridgewater Advisors first reported a position in Novo Nordisk in Q4 2013 and has held it in 12 quarters since.
  • Bridgewater Advisors's Novo Nordisk position peaked at $1.6M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.